Medicine background
Semaglutide
An active ingredient in licensed prescription medicines for specified uses.
Also discussed as: GLP-1 · Wegovy · Ozempic · Rybelsus
THE RESEARCH QUESTION
What is being investigated?
GLP-1 receptor activity is relevant to blood glucose and appetite. Indications depend on the particular licensed medicine.
EVIDENCE SNAPSHOT
UK licensed medicines exist
This is not a research-only substance in every formulation. Prescription use requires an assessment and adherence to the medicine’s authorised information.
LIMITS & SAFETY
What should you know?
Side effects and suitability need clinical review. Severe persistent abdominal pain needs urgent medical attention.
FOLLOW THE EVIDENCE
Sources & further reading
- MHRA: GLP-1 medicines, approved uses and safety ↗UK regulator
- MHRA: strengthened warnings on pancreatitis (2026) ↗UK regulator
Checked 8 October 2026. Sources may describe different populations, formulations and jurisdictions. This overview is not a systematic review or individual medical advice.
PUT THE EVIDENCE IN CONTEXT
Questions about what you’ve read?
Request an educational conversation with Matthew about the evidence and questions to raise with your medical professional.